Sysmex Canada introduces new hematology analyzers

Sysmex Canada, providers of automated hematology and urinalysis diagnostic testing, has launched the new XN-L Series for testing in smaller analytic devices.

The XN-L is designed for smaller healthcare organizations that do not need the larger XN-Series analyzer, making the system affordable while still maintaining quality results. The system integrates with laboratories that require a high quality backup.

"We are pleased to be able to offer the XN-L Series of hematology analyzers to the Canadian healthcare market," said Carl Rocha, general manager at Sysmex. "The XN-L Series complements our flagship XN-Series analyzers by serving the lower volume end of the healthcare spectrum. The XN-L can also serve as a high-quality backup for larger labs, especially those with an XN-Series analyzer, offering standardization of reagents and controls across all test volume segments."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.